查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1831972

热原检测市场报告，按产品（仪器、试剂盒和试剂、服务）、检测类型（体外检测、LAL 检测、兔子检测等）、应用（製药和生物製剂、医疗器材等）和地区划分，2025 年至 2033 年

Pyrogen Testing Market Report by Product (Instruments, Kits and Reagents, Services), Test Type (In-vitro Tests, LAL Tests, Rabbit Tests, and Others), Application (Pharmaceutical and Biologics, Medical Devices, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球热原检测市场规模达15亿美元。展望未来， IMARC Group预计到2033年，该市场规模将达到33亿美元，2025-2033年期间的复合年增长率（CAGR）为8.71%。全球製药和生物技术产业的蓬勃发展，心臟病、癌症和糖尿病等慢性疾病的发病率不断上升，新疗法的推出以及研发资金的不断增加，共同推动着该市场的发展。

热原检测市场趋势：

法规遵从和安全标准

热原检测市场的成长在很大程度上得益于美国食品药物管理局 (FDA) 和欧洲药品管理局 (EMA) 等卫生当局实施的严格监管框架。美国医疗器材促进协会 (AAMI) ST72:2002/R2010《细菌内毒素检测方法、常规监测和批量检测替代方法》(AAMI ST72) 描述了凝胶凝块法、光度法和动力学检测方法的基本原理，并建议对相应的组件和成品进行热原和内毒素检测。这些法规要求对药品、医疗器材和生物製品进行严格的安全测试，以确保它们不含可能引起发烧并对患者造成严重风险的热原。因此，製造商正在将热原检测纳入其生产流程。

製药和生物技术产业的进步

製药和生物技术行业的成长以及生物製剂产量的增加也为热原检测市场创造了良好的前景。源自生物体的生物製剂易受热原污染。根据 IMARC GROUP 的数据，2023 年全球生物製剂市场规模达 3,496 亿美元。展望未来，预计到 2032 年热原检测市场价值将达到 6,995 亿美元，2024-2032 年期间的复合年增长率 (CAGR) 为 7.8%。随着这些行业的扩张，对复杂、可靠和快速的热原检测方法的需求也在增加。此外，这种需求导致了检测技术的创新，例如重组 C 因子 (rFC) 检测，它为传统的鲎血液衍生检测提供了一种合成替代方法。

发展医疗基础设施

新兴经济体医疗基础设施的不断发展，以及对符合国际安全标准（包括无热原认证）的医疗产品日益增长的需求，正在推高热原检测的需求。这种扩张拓宽了热原检测的地理市场，并迫使本地製造商采用先进的检测技术参与全球市场。此外，医疗保健体系的发展和医疗支出的增加，也促进了先进热原检测流程的采用和整合。此外，政府部门也正在投资医疗保健产业，以促进公共卫生发展。例如，美国疾病管制与预防中心已拨款32亿美元，协助美国各州、地方和领地辖区加强公共卫生队伍建设和基础建设。这32亿美元中，有30亿美元来自《美国救援计画法案》，用于各辖区招募、留住和培训其员工队伍，包括流行病学家、接触追踪员、实验室科学家、社区卫生工作者和资料分析师等关键的第一线公共卫生工作者。这笔资金还包括从新拨款中拨出的 1.4 亿美元，用于各辖区加强和振兴其公共卫生基础设施。

热原测试市场细分：

按产品分类：

  • 仪器
  • 试剂盒和试剂
  • 服务

试剂盒和试剂占大部分市场份额

试剂盒和试剂易于使用，实验室人员无需大量专业培训即可快速设定和执行检测。这种便捷性缩短了检测週期。此外，预先包装的试剂盒和试剂比内部检测方法更具成本效益。自製检测试剂的研发、验证和品质控製成本可能高得令人望而却步，尤其对于规模较小的公司而言。此外，各公司正在透过收购、合併和推出新的先进产品来扩大其热原检测市场份额。例如，PromegaCorp. 于 2021 年 3 月推出了 XpressAmp Direct 扩增试剂。

按测试类型分类：

  • 体外测试
  • LAL 测试
  • 兔子测试
  • 其他的

LAL 检测占据业界最大份额

鲎试剂 (LAL) 检测对细菌内毒素高度敏感，能够检测到极低浓度的内毒素。这些检测的灵敏度对于确保药品和医疗器材的安全至关重要。此外，由于其可靠性得到验证，LAL 检测已成为内毒素检测的标准方法，并受到监管机构和製造商的广泛信赖。此外，LAL 检测也获得了包括美国食品药物管理局 (FDA) 和欧洲药典在内的主要监管机构的认可和建议。 30 多年来，FDA 一直认可使用鲎试剂 (LAL) 检测内毒素，以取代兔热原检测。

按应用分类：

  • 製药和生物製剂
  • 医疗器材
  • 其他的

製药和生物製剂是领先的细分市场

在生物技术进步和个人化医疗日益受到重视的推动下，生物製剂产业正在快速成长。随着越来越多的生物製剂进入研究流程和商业化生产，这种扩张导致对热原检测的需求增加。此外，製药和生技公司正在大力投资研发新药和生物製品，这需要进行严格的安全测试，包括热原检测，以确保这些创新产品对人类使用是安全的。例如，总部位于加州的安进公司在研发活动上投入了大量资金，根据其 2021 年公司年度报告，其 2021 年、2020 年和 2019 年的研发支出分别为 48 亿美元、42 亿美元和 41 亿美元。这些因素正在扩大这些测试在製药和生物製剂中的应用，从而为热原检测市场带来积极的预测。

按地区划分：

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

北美引领市场，占据最大热原检测市场份额

该报告还对所有主要区域市场进行了全面分析，包括北美（美国和加拿大）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告指出，北美是热原检测最大的区域市场。

北美拥有先进的医疗保健基础设施，高度重视法规遵循和病人安全。这些基础设施支援并要求医疗产品达到高标准，从而影响了对热原检测的需求，以确保药品和医疗器材的安全。此外，北美的医疗保健支出位居世界前列，大量支出用于医疗创新，包括安全检测。根据医疗保险和医疗补助服务中心的数据，美国医疗保健支出在 2022 年增长了 4.1%，达到 4.5 兆美元，高于 2021 年 3.2% 的增幅。此外，2022 年零售处方药支出成长了 8.4%，达到 4,059 亿美元，高于 2021 年 6.8% 的增幅。这种经济实力正在加剧整个医疗保健和製药业对热原检测的需求。

本报告回答的关键问题：

  • 全球热原检测市场迄今表现如何，未来几年将如何表现？
  • 全球热原检测市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球热原检测市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表了最具吸引力的热原检测市场？
  • 根据产品，市场是如何分類的？
  • 热原检测市场上最有吸引力的产品是什么？
  • 根据测试类型，市场区隔如何？
  • 热原检测市场中哪种检测类型最具吸引力？
  • 根据应用，市场是如何分類的？
  • 热原检测市场中最吸引人的应用是什么？
  • 市场的竞争结构是怎么样的？
  • 全球热原检测市场的主要参与者/公司有哪些？

本报告回答的关键问题：

  • 全球热原检测市场迄今表现如何，未来几年将如何表现？
  • 全球热原检测市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球热原检测市场有何影响？
  • 主要的区域市场有哪些？
  • 哪些国家代表了最具吸引力的热原检测市场？
  • 根据产品，市场是如何分類的？
  • 热原检测市场上最有吸引力的产品是什么？
  • 根据测试类型，市场区隔如何？
  • 热原检测市场中哪种检测类型最具吸引力？
  • 根据应用，市场是如何分類的？
  • 热原检测市场中最吸引人的应用是什么？
  • 市场的竞争结构是怎么样的？
  • 全球热原检测市场的主要参与者/公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球热原检测市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 仪器
  • 试剂盒和试剂
  • 服务

第七章：市场区隔：依测试类型

  • 体外测试
  • 鲎试剂测试
  • 兔子测试
  • 其他的

第 8 章：市场区隔：按应用

  • 製药和生物製剂
  • 医疗器材
  • 其他的

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Charles River Laboratories International Inc.
    • Ellab A/S
    • Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
    • Lonza Group AG
    • Merck KGaA
    • Microcoat Biotechnologie GmbH
    • Nelson Laboratories LLC (Sotera Health)
    • North American Science Associates Inc.
    • Pacific Biolabs Inc.
    • Sanquin
    • Thermo Fisher Scientific Inc
    • Toxikon Corporation
    • Wuxi Apptec
Product Code: SR112025A4601

The global pyrogen testing market size reached USD 1.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 8.71% during 2025-2033. The market is propelled by the expanding pharmaceutical and biotechnology industries around the world, the increasing prevalence of chronic ailments such as heart diseases, cancer, and diabetes, and the launch of the new therapeutics and rising funding of research and development (R&D) activities.

Pyrogen Testing Market Trends:

Regulatory compliance and safety standards

The pyrogen testing market growth is significantly driven by the implementation of stringent regulatory frameworks by health authorities such as the FOOD and DRUGS ADMINISTRATION in the United States and the EUROPEAN MEDICINE AGENCY in Europe. The Association for the Advancement of Medical Instrumentation (AAMI) ST72:2002/R2010, Bacterial Endotoxins-Test Methodologies, Routine Monitoring, and Alternatives to Batch Testing (AAMI ST72) are documents that describe the fundamental principles of the gel clot, photometric, and kinetic test methods, and recommend that appropriate components and finished products be tested for the presence of pyrogens and endotoxins. These regulations require rigorous safety testing of pharmaceuticals, medical devices, and biological products to ensure they are free of pyrogens, which can induce fever and pose severe risks to patients. As a result, manufacturers are incorporating pyrogen testing in their production processes.

Advancements in pharmaceuticals and biotechnology industries

The growth of the pharmaceutical and biotechnology sectors and the increasing biologics production is also creating a favorable pyrogen testing market outlook. Biologics, derived from living organisms are susceptible to contamination by pyrogens. According to IMARC GROUP, the global biologics market size reached US$ 349.6 Billion in 2023. Looking forward, the pyrogen testing market value is expected to reach US$ 699.5 Billion by 2032, exhibiting a growth rate (CAGR) of 7.8% during 2024-2032. As these industries expand, the requirement for sophisticated, reliable, and rapid pyrogen testing methods is also increasing. Moreover, this demand is leading to innovations in testing technologies, such as recombinant factor C (rFC) assays, which offer a synthetic alternative to traditional horseshoe crab blood-derived tests.

Developing healthcare infrastructure

The developing healthcare infrastructure in emerging economies and the increasing need for medical products that meet international safety standards, including pyrogen-free certifications is escalating the pyrogen testing demand. This expansion broadens the geographic market for pyrogen testing and compels local manufacturers to adopt advanced testing technologies to participate in global markets. Moreover, the development of healthcare systems and the increased healthcare spending is increasing the adoption and integration of advanced pyrogen testing processes. Besides, government authorities are also investing in the healthcare industry to promote public health. For instance, CENTER for DISEASE CONTROL and PREVENTION has awarded $3.2 billion to help state, local, and territorial jurisdictions across the United States strengthen their public health workforce and infrastructure. The $3.2 billion includes $3 billion from the AMERICAN RESCUE PLAN ACT for jurisdictions to recruit, retain, and train their workforce, including critical frontline public health workers such as epidemiologists, contact tracers, laboratory scientists, community health workers, and data analysts. The funding also includes $140 million from a new appropriation for jurisdictions to strengthen and revitalize their public health infrastructure.

Pyrogen Testing Market Segmentation:

Breakup by Product:

  • Instruments
  • Kits and Reagents
  • Services

Kits and reagents accounts for the majority of the market share

Kits and reagents are user-friendly allowing for quick setup and execution of tests by laboratory personnel without the need for extensive specialized training. This convenience leads to faster turnaround times in testing. Besides, pre-packaged kits and reagents are more cost-effective than in-house testing methods. The costs associated with R&D, validation, and quality control of self-made tests can be prohibitively high, especially for smaller companies. Moreover, companies are acquiring and merging with other companies and launching new advanced products to expand their pyrogen testing market share. For instance, in March 2021, PromegaCorp. launched XpressAmp Direct amplification reagent.

Breakup by Test Type:

  • In-vitro Tests
  • LAL Tests
  • Rabbit Tests
  • Others

LAL tests hold the largest share of the industry

LAL tests are highly sensitive to bacterial endotoxins, capable of detecting them at very low levels. The sensitivity of these tests is crucial for ensuring the safety of pharmaceuticals and medical devices. Moreover, due to its proven reliability, the LAL test has become the standard method for endotoxin testing and is widely trusted by regulatory authorities and manufacturers. Besides, the LAL test is recognized and recommended by major regulatory bodies, including the U.S. Food and Drug Administration (FDA) and the European Pharmacopoeia. For more than 30 years, FDA has accepted the use of a Limulus Amoebocyte Lysate (LAL) test for endotoxins in lieu of the rabbit pyrogens test.

Breakup by Application:

  • Pharmaceutical and Biologics
  • Medical Devices
  • Others

Pharmaceutical and biologics represents the leading market segment

The biologics sector is growing rapidly, driven by advancements in biotechnology and an increasing focus on personalized medicine. This expansion contributes to a greater demand for pyrogen testing as more biologics enter research pipelines and commercial production. Moreover, pharmaceutical and biotechnology companies are investing heavily in research and development to create new drugs and biological products which necessitate rigorous safety testing, including pyrogen testing, to ensure that these innovations are safe for human use. For instance, California-based Amgen Inc. invests heavily in its research and development activities and its expenditure for research and development was US$ 4.8 Billion, US$ 4.2 Billion, and US$ 4.1 Billion, for 2021, 2020, and 2019, respectively, as per its 2021 company annual report. These factors are expanding the use of these testing in pharmaceutical and biologics thus creating a positive pyrogen testing market forecast.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

North America leads the market, accounting for the largest pyrogen testing market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for pyrogen testing.

North America boasts an advanced healthcare infrastructure with a strong emphasis on regulatory compliance and patient safety. This infrastructure supports and demands high standards for medical products, influencing the need for pyrogen testing to ensure the safety of pharmaceuticals and medical devices. Besides, the healthcare expenditure in North America is among the highest in the world, with significant spending allocated to health innovation, including safety testing. According to the CENTERS FOR MEDICARE & MEDICAID SERVICES, the United States healthcare spending grew 4 pending grew 4.1% to reach $4.5 Trillion in 2022, faster than the increase of 3.2% in 2021. Besides, retail prescription drug spending increased 8.4% to $405.9 Billion in 2022, a faster rate than in 2021 when spending increased by 6.8%. This financial capability is escalating the need for pyrogen testing, across the healthcare and pharmaceutical sectors.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the pyrogen testing industry include Charles River Laboratories International Inc., Ellab A/S, Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation), Lonza Group AG, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories LLC (Sotera Health), North American Science Associates Inc., Pacific Biolabs Inc., Sanquin Reagents BV, Thermo Fisher Scientific Inc, Toxikon Corporation and Wuxi Apptec.
  • The pyrogen testing market research report shows that leading companies are continually investing in research and development to improve existing products and create new, more efficient, and sensitive pyrogen testing methods. This includes the development of rapid tests and alternative methods like the monocyte activation test (MAT) and recombinant factor C (rFC) assay. Moreover, companies are increasingly focusing on expanding their presence in high-growth regions such as Asia-Pacific and Latin America as these regions offer significant opportunities due to their rapidly expanding pharmaceutical and medical device manufacturing sectors. According to IMARC Group, the India pharmaceutical market size reached US$ 54.6 Billion in 2023. Looking forward, it is expected to reach US$ 163.1 Billion by 2032, exhibiting a growth rate (CAGR) of 12.3% during 2024-2032. These values will continue to impact the pyrogen testing market statistics in the coming years.

Key Questions Answered in This Report:

  • How has the global pyrogen testing market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global pyrogen testing market?
  • What is the impact of each driver, restraint, and opportunity on the global pyrogen testing market?
  • What are the key regional markets?
  • Which countries represent the most attractive pyrogen testing market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the pyrogen testing market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the pyrogen testing market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the pyrogen testing market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global pyrogen testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pyrogen Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Kits and Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 In-vitro Tests
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 LAL Tests
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Rabbit Tests
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Pharmaceutical and Biologics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Devices
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Charles River Laboratories International Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Ellab A/S
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Fujifilm Wako Pure Chemical Corporation (Fujifilm Holdings Corporation)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Lonza Group AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Merck KGaA
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Microcoat Biotechnologie GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Nelson Laboratories LLC (Sotera Health)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 North American Science Associates Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Pacific Biolabs Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sanquin
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Thermo Fisher Scientific Inc
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Toxikon Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wuxi Apptec
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials

List of Figures

  • Figure 1: Global: Pyrogen Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Pyrogen Testing Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Pyrogen Testing Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Pyrogen Testing Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Pyrogen Testing Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: Pyrogen Testing Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Pyrogen Testing Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Pyrogen Testing (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Pyrogen Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Pyrogen Testing (Kits and Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Pyrogen Testing (Kits and Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Pyrogen Testing (Services) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Pyrogen Testing (Services) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Pyrogen Testing (In-vitro Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Pyrogen Testing (In-vitro Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Pyrogen Testing (LAL Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Pyrogen Testing (LAL Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Pyrogen Testing (Rabbit Tests) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Pyrogen Testing (Rabbit Tests) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Pyrogen Testing (Other Test Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Pyrogen Testing (Other Test Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Pyrogen Testing (Pharmaceutical and Biologics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Pyrogen Testing (Pharmaceutical and Biologics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Pyrogen Testing (Medical Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Pyrogen Testing (Medical Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Pyrogen Testing (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Pyrogen Testing (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Pyrogen Testing Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Pyrogen Testing Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Pyrogen Testing Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Pyrogen Testing Industry: SWOT Analysis
  • Figure 78: Global: Pyrogen Testing Industry: Value Chain Analysis
  • Figure 79: Global: Pyrogen Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pyrogen Testing Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Pyrogen Testing Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Pyrogen Testing Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 4: Global: Pyrogen Testing Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Pyrogen Testing Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Pyrogen Testing Market: Competitive Structure
  • Table 7: Global: Pyrogen Testing Market: Key Players